Looking for the latest in oncology clinical literature? You've found the right page. MDLinx Oncology medical editors comb through the top peer-reviewed clinical journals for the articles they think will make a difference to you and your practice. You'll find them organized here by topic including breast, hematologic, thoracic, gastrointestinal and genitourinary cancers. In a matter of minutes, oncologists, oncology nurses, physician assistants and the whole cancer care team can stay current on the literature as it is published.
On this page, you'll also find MDLinx exclusive content, including monthly highlights from our physician editor, D. Scott Cunningham, MD, PhD. We feature clinical pearls as well, from The Smartest Oncologist to oncology topics in The Smartest Pediatrician daily quiz challenges.
Your Unread Messages in Oncology
See All >> Messages include industry-sponsored communications and special communications from MDLinx
Patients 50+ may be at increased risk for pneumococcal disease. Learn what you can do.
Smartest Doc Challenge
MDLinx
Pediatric Oncology Clinical Pearls
D Scott Cunningham MD, PhD
Site Editor, MDLinx
Transition rates for adenomas to CRC
Jill Baker
MDLinx Career Center
New Jobs in Your Specialty
MDLinx Top Read
MDLinx
Are your journals collecting cobwebs?
MDLinx Conference Center
MDLinx
June Conference Calendar
1 DMET (Drug-Metabolizing Enzymes and Transporters) microarray analysis of colorectal cancer patients with severe 5-fluorouracil-induced toxicity Cancer Chemotherapy and Pharmacology, June 17, 2013 Clinical Article
2 Incidence of supraventricular arrhythmias during autologous peripheral blood stem cell transplantation Biology of Blood and Marrow Transplantation, June 17, 2013 Clinical Article
3 Efficacy of a supersaturated calcium phosphate oral rinse for the prevention and treatment of oral mucositis in patients receiving high-dose cancer therapy: a review of current data European Journal of Cancer Care, June 17, 2013 Clinical Article
4 Hair mass index obtained by cross-section trichometry: an objective and clinically useful parameter to quantify hair in chemotherapy-induced alopecia Supportive Care in Cancer, June 13, 2013 Clinical Article
5 Development of acneiform rash does not predict response to lapatinib treatment in patients with breast cancer Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, June 11, 2013 Clinical Article
6 Randomized double-blind placebo-controlled trial of acetyl-L-carnitine for the prevention of taxane-induced neuropathy in women undergoing adjuvant breast cancer therapy Journal of Clinical Oncology, June 10, 2013 Clinical Article
7
Depression and anxiety in long-term cancer survivors compared with spouses and healthy controls: a systematic review and meta-analysis
The Lancet Oncology, June 7, 2013
Exclusive Author Commentary
8 CYP3A4*22 Genotype and Systemic Exposure Affect Paclitaxel-Induced Neurotoxicity Clinical Cancer Research, June 6, 2013 Clinical Article
9 Development of psoriasis in a patient with chronic myelogenous leukaemia during nilotinib treatment European Journal of Haematology, June 6, 2013 Clinical Article
10 Impact of cabazitaxel on 2-year survival and palliation of tumour-related pain in men with metastatic castration-resistant prostate cancer treated in the TROPIC trial Annals of Oncology, June 5, 2013 Clinical Article
11 Cutaneous complications in hematopoietic cell transplant recipients: impact of biopsy on patient management Biology of Blood and Marrow Transplantation, June 5, 2013 Clinical Article
12 Incidence of chemotherapy-induced neutropenia and current practice of prophylaxis with granulocyte colony-stimulating factors in cancer patients in Spain: a prospective, observational study European Journal of Cancer Care, June 5, 2013 Clinical Article
13 Prevalence of iron deficiency across different tumors and its association with poor performance status, disease status and anemia Annals of Oncology, June 4, 2013 Clinical Article
14 Relationships between hepatitis B infection status and liver dysfunction after chemotherapy of lung cancer patients in mainland China Supportive Care in Cancer, June 4, 2013 Clinical Article
15 D-index dose not predict the development of pulmonary infection in acute myeloid leukemia patients undergoing consolidation chemotherapy with high-dose cytarabine Hematology, June 3, 2013 Clinical Article
16 Resolution of clostridium difficile-associated diarrhea in patients with cancer treated with fidaxomicin or vancomycin Journal of Clinical Oncology, May 31, 2013 Clinical Article
17 Long-term survival with low toxicity after allogeneic transplantation for acute myeloid leukaemia and myelodysplasia using non-myeloablative conditioning without T cell depletion British Journal of Haematology, May 31, 2013 Clinical Article
18 Role of cardioprotective therapy for prevention of cardiotoxicity with chemotherapy: a systematic review and meta-analysis European Journal of Cancer, May 29, 2013 Evidence Based Medicine Review Article
19 Toxicity and prognosis in overweight and obese women with lung cancer receiving carboplatin-paclitaxel doublet chemotherapy Cancer Investigation, May 23, 2013 Clinical Article
20 High response rate and acceptable toxicity of a combination of rituximab, vinorelbine, ifosfamide, mitoxantrone and prednisone for the treatment of diffuse large B-cell lymphoma in first relapse: results of the R-NIMP GOELAMS study British Journal of Haematology, May 23, 2013 Clinical Article
As reported in the Journal of Pathology, the expression of vascular endothelial growth factor receptor (VEGFR)-1 is elevated in invasive hepatocellular cancer (HCC) specimens. In a study based on 135 HCC specimens, elevated VEGFR-1 was also associated with worse recurrence-free and overall survival.
Read the article summaryAs reported in Cancer, researchers from the NCI have reported that patients with AIDS have a 4-fold increased risk of HCC compared to the general population. The study findings were based on 615,150 patients with AIDS between 1980 and 2009. The risk for HCC in patients with AIDS was essentially the same during the monotherapy/dual therapy and highly active anti-retroviral therapy eras.
Read the article summaryAs reported in the International Journal of Cancer Research and Treatment, the pre-operative level of RAB25 is a predictor of disease-free survival (HR=18.2) and overall survival (HR=33.6) in patients with ovarian cancer. The study involved 36 and 16 women with ovarian cancer and benign tumors, respectively. The pre-operative cell-free DNA of genes (B2M, RAB25, CLDN4, and ABCF2) were measured and RAB25 was shown to be an independent prognostic factor.
Read the article summaryIndexed Journals in Oncology: Journal of Clinical Oncology, Cancer Research, Annals Oncology more
Register now to view all the MDLinx contents (FREE)!
Login
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close